ABC | Volume 110, Nº3, Março 2018

Artigo de Revisão Ker et al Implicações práticas da pesquisa de viabilidade miocárdica Arq Bras Cardiol. 2018; 110(3):278-288 Este um artigo de acesso aberto distribuído sob os termos da licen a de atribui ão pelo Creative Commons 59. Beller GA, Ragosta M. Extent of myocardial viability in regions of left ventricular dysfunction by rest-redistribution thallium-201 imaging: a powerful predictor of outcome.; J Nucl Cardiol. 1998;5(4):445-8. 60. Ramani K, Judd RM, Holly TA, Parrish TB, Rigolin VH, Parker MA, et al. Contrast magnetic resonance imaging in the assessment of myocardial viability in patients with stable coronary artery disease and left ventricular dysfunction.; Circulation. 1998;98(24):2687-94. 61. LeeVS,ResnickD,TiuSS,Sanger JJ,NazzaroCA, IsraelGM, etal.MR imaging evaluation of myocardial viability in the set of equivocal SPECT results with 99m Tc-sestamibi. Radiology. 2004;230(1):191-7. 62. Alderman EL, Fisher LD, Litwin P, Kaiser GC, Myers WO, Maynard C, et al. Results of coronary artery surgery in patients with poor left ventricular function (CASS). Circulation. 1983;68(4):785-95. 63. Velazquez EJ, Lee KL, Jones RH, Al-Khalidi HR, Hill JA, Panza JA, et al; STICHES Investigators. Coronary-artery bypass surgery in patients with ischemic cardiomyopathy.; N Engl J Med. 2016;374(16):1511-20. 64. Shah B.N.; Khattar R.S.; Senior R.; The hibernating myocardium: current concepts, diagnostic dilemmas, and clinical challenges in the post-STICH era.; Eur Heart J 2013;34:1323–36 65. Desideri A.; Cortigiani L.; Christen A.I.; et al.; The extent of perfusion–F18- fluorodeoxyglucose positron emission tomography mismatch determines mortality inmedically treated patients with chronic ischemic left ventricular dysfunction.; J Am Coll Cardiol 2005;46:1264–9. 66. Van Loon, R.B.; Veen G.; Baur L. HB; Kamp O.; Bronzwaer J. GF.; Twisk J. W. R.; Verheugt F. WA; Van Rossum, A. C.; Improved clinical outcome after invasive management of patients with recent myocardial infarction and provenmyocardial viability: primary results of a randomized controlled trial (VIAMI-trial); Trials 2012, 13:1 67. Peter Carson P.; Wertheimer J.; Alan Miller A.; O’Connor C. M.; Ileana L. Pina I. L.; Selzman C.; Sueta C.; She L.; Greene D.; Lee K. L.; Jones R. H.; Velazquez E. J.; for the STICH Investigators; The STICH Trial (Surgical Treatment for Ischemic Heart Failure); JACC: Heart Failure, Vol.1, No. 5, 2013. 68. Beanlands R.S.B.; Nichol G.; Huszti E.; et al.; PARR-2 Investigators. F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).; J Am Coll Cardiol 2007;50:2002–12. 288